HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of Dotarizine (Ca2+ channel blocker) on cerebral vessel reactivity in animals subjected to hyperventilation and anoxia.

Abstract
Dotarizine--a novel piperazine derivative--belongs to wide spectrum Ca+ channel antagonists. It was reported to have strong vasodilatory and antiserotoninergic activities. Unlike other Ca+ channel blockers Dotarizine was found to have lower oral toxicity. In the presented study the influence of the oral administration of the novel compound on the blood flow velocity changes in different cerebral arteries--in basilar artery (BA) and middle cerebral artery (MCA)--was investigated under hyperventilation and hypoxic conditions of rabbits. In the first experimental group 25 mg/kg of Dotarizine dissolved in 0.25% agar was administered orally three times at the 10 hours' intervals. The sham group of animals was fed with agar of the same concentration. The results revealed that oral administration of Dotarizine diminished the vasoconstrictive effect of hyperventilation and this was more pronounced in MCA than in BA. During anoxic conditions stronger vasodilatory effects were observed in both groups of vessels and the low value of pulsatility index (PI) reflected pronounced decrease of the peripheral resistance, in comparison to the control group. Thus, the oral administration of Dotarizine decreases the peripheral resistance of cerebral vessels and therefore seems to have influence on the minute arteries of cerebrovascular system of the brain.
AuthorsZ Czernicki, N Kuridze, J Jurkiewicz, J Cervós-Navarro
JournalActa neurochirurgica. Supplement (Acta Neurochir Suppl) Vol. 70 Pg. 209-11 ( 1997) ISSN: 0065-1419 [Print] Austria
PMID9416324 (Publication Type: Journal Article)
Chemical References
  • Benzhydryl Compounds
  • Calcium Channel Blockers
  • Piperazines
  • Vasodilator Agents
  • dotarizine
Topics
  • Animals
  • Benzhydryl Compounds (therapeutic use)
  • Blood Flow Velocity (drug effects)
  • Calcium Channel Blockers (therapeutic use)
  • Cerebral Arteries (drug effects)
  • Female
  • Hyperventilation (drug therapy)
  • Hypoxia, Brain (drug therapy)
  • Male
  • Piperazines (therapeutic use)
  • Rabbits
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: